International Stem Cell (ISCO) Net Cash Flow (2010 - 2025)
International Stem Cell (ISCO) reported Net Cash Flow of $27,000 for Q4 2025, compared with -$77,000 a year earlier and down 41.3% from the prior quarter.
Powered by 
Analysis
International Stem Cell (ISCO) Net Cash Flow (2010 - 2025) Analysis & Trends
For FY2025, International Stem Cell posted Net Cash Flow of -$237,000.
- By year, Net Cash Flow came in at -$358,000 in FY2024, $846,000 in FY2023 (+48.2%), $571,000 in FY2022 and -$518,000 in FY2021.
- Five-year quarterly Net Cash Flow spans a low of -$367,000 in Q2 2021 and a high of $439,000 in Q2 2023.
- The high point for year-over-year Net Cash Flow in five years was Q3 2024 (growth of 352.1%); the low point was Q3 2025 (a decline of 78.8%).
- Per Business Quant data, the three quarters before Q4 2025 came in at $46,000 (Q3 2025), -$332,000 (Q2 2025) and $222,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 3.72 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | -1.27 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | -2.82 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 1.53 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 757.00 Mn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | -3.94 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 1.95 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | -4.43 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | -722.00 Mn |
| 10 | International Stem Cell | 2.08 Mn | -1.89 Mn | 1.46 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 27,000.00 |
| Sep 30, 2025 | 46,000.00 |
| Jun 30, 2025 | -332,000.00 |
| Mar 31, 2025 | 222,000.00 |
| Dec 31, 2024 | -77,000.00 |
| Sep 30, 2024 | 217,000.00 |
| Jun 30, 2024 | -96,000.00 |
| Mar 31, 2024 | -202,000.00 |
| Dec 31, 2023 | 158,000.00 |
| Sep 30, 2023 | 48,000.00 |
| Jun 30, 2023 | 439,000.00 |
| Mar 31, 2023 | 201,000.00 |
| Dec 31, 2022 | 76,000.00 |
| Sep 30, 2022 | 80,000.00 |
| Jun 30, 2022 | 192,000.00 |
| Mar 31, 2022 | 227,000.00 |
| Dec 31, 2021 | -334,000.00 |
| Sep 30, 2021 | -245,000.00 |
| Jun 30, 2021 | -367,000.00 |
| Mar 31, 2021 | 428,000.00 |
API Access
International Stem Cell Net Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-cash-flow&ticker=ISCO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-cash-flow", "ticker": "ISCO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-cash-flow&ticker=ISCO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();